Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,487.00
  • Today's Change-26.50 / -1.75%
  • Shares traded8.17m
  • 1 Year change-33.59%
  • Beta0.7222
Data delayed at least 20 minutes, as of May 17 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,603,6721,518,6191,296,163
OPERATING EXPENSES
Cost of revenue total292,485288,353253,009
Selling, general and admin. expenses, total740,110630,272548,840
Depreciation/amortization98,82038,43628,283
Unusual expense(income)(9735)94,76666,036
Other operating expenses, total159,12253,7781,876
Total operating expense1,578,1541,390,5971,135,393
Operating income25,518128,022160,770
Other, net1.002,304(2430)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes24,969132,361156,886
Provision for income taxes7,92433,64732,800
Net income after taxes17,04598,714124,086
Minority interest------
Net income before extra. Items17,04598,714124,086
Total extraordinary items------
Net income17,04598,714124,086
Inc.avail. to common excl. extra. Items17,04598,714124,086
Inc.avail. to common incl. extra. Items17,04598,714124,086
EPS RECONCILIATION
Basic/primary weighted average shares1,7931,8201,850
Basic/primary eps excl. extra items9.505467
Basic/primary eps incl. extra items9.505467
Dilution adjustment------
Diluted weighted average shares1,7931,8251,851
Diluted eps excl. extra items9.505467
Diluted eps incl. extra items9.505467
COMMON STOCK DIVIDENDS
DPS - common stock primary issue706050
Gross dividend - common stock--109,31592,392
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental--3,2172,315
SUPPLEMENTAL INCOME
Depreciation, supplemental59,02040,02140,059
Total special items(9735)94,76666,036
NORMALISED INCOME
Normalized income before taxes15,234227,127222,922
Effect of special items on income taxes(3089)24,09013,806
Income tax excluding impact of special items4,83557,73746,606
Normalized income after tax10,399169,390176,316
Normalized income avail. to common10,399169,390176,316
Basic normalized EPS5.809395
Diluted normalized EPS5.809395
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.